Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q3 2022
Institutional positions in Silence Therapeutics plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +4 vs. Q2 2022
- Shares held
- 18.7M
- +8.29M (+80.0%) vs. Q2 2022
- Total value
- $183.4M
- +$67.0M (+57.6%) vs. Q2 2022
- New holders
- 7
- 9 more added
- Sold out
- 3
- 5 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lombard Odier Asset Management (USA) Corp | 3,896,595 | $35.7M | 5.12% | +130,226+3.5% | Added |
| Lombard Odier Asset Management (Europe) Ltd | 3,219,400 | $32.3M | 1.68% | +3,219,400 | New |
| TCG Crossover Management, LLC | 2,104,875 | $21.1M | 6.34% | +2,104,875 | New |
| Deep Track Capital, LP | 1,951,580 | $19.6M | 0.97% | +1,000,000+105.1% | Added |
| BVF Inc | 1,508,416 | $14.9M | 0.61% | +841,750+126.3% | Added |
| Aquilo Capital Management, LLC | 1,263,125 | $12.7M | 5.33% | +1,263,125 | New |
| Frazier Life Sciences Management, L.P. | 881,173 | $8.70M | 0.67% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 700,000 | $7.03M | 0.02% | +135,000+23.9% | Added |
| Goldman Sachs Group Inc | 660,000 | $6.62M | 0.00% | 00.0% | Unchanged |
| AXA S.A. | 641,666 | $6.44M | 0.03% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 550,875 | $5.53M | 0.02% | +300,875+120.4% | Added |
| Cantor Fitzgerald, L. P. | 209,886 | $2.11M | 0.05% | −1,574−0.7% | Reduced |
| HSBC Holdings PLC | 177,834 | $1.75M | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 155,159 | $1.56M | 0.00% | +1,866+1.2% | Added |
| Parkman Healthcare Partners LLC | 127,458 | $1.28M | 0.36% | +101,208+385.6% | Added |
| Woodline Partners LP | 115,120 | $1.16M | 0.02% | +115,120 | New |
| SG Americas Securities, LLC | 98,953 | $977.0K | 0.01% | −2,500−2.5% | Reduced |
| UBS Oconnor LLC | 79,636 | $786.0K | 0.01% | +50,820+176.4% | Added |
| Great Point Partners LLC | 68,915 | $692.0K | 0.17% | −332,534−82.8% | Reduced |
| UBS Group AG | 65,815 | $660.0K | 0.00% | −3,440−5.0% | Reduced |
| Citigroup Inc | 58,333 | $576.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 41,887 | $420.0K | 0.00% | −9,288−18.1% | Reduced |
| WS Management LLLP | 25,000 | $251.0K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,851 | $226.0K | 0.00% | +11,410+99.7% | Added |
| Millennium Management LLC | 14,557 | $144.0K | 0.00% | +14,557 | New |
| Geode Capital Management, LLC | 13,177 | $130.0K | 0.00% | +13,177 | New |
| Deutsche Bank AG | 3,953 | $40.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 500 | $5.00K | 0.00% | +500 | New |
| Steward Partners Investment Advisory, LLC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −634,270−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −30,483−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −120−100.0% | Sold out |